Peptides retodutide 10mg CAS: {2805997-46-8

Peptides retodutide 10mg CAS: {2805997-46-8
Khoom Taw qhia:
Survodutide yog ib hom tshuaj peptide tshiab, yog ib qho tseem ceeb ntawm cov neeg siv tshuaj kho mob hauv kev tshawb fawb txog kev kho mob thiab kev kho mob, nrog rau cov peev txheej dav dav, feem ntau yog siv los tiv thaiv qog, immunomodulatory thiab lwm yam kab mob metabolic. Nws inhibits qog hlwb los ntawm kev tsom mus rau cov cell receptors tshwj xeeb, tshwj xeeb tshaj yog thaum tsom rau qee hom mob qog noj ntshav, qhia txog kev kho mob zoo dua. Cov txheej txheem ntawm survodutide cuam tshuam nrog kev khi rau cov receptors ntawm cov cell membrane, ua kom cov kev taw qhia downstream, inducing cell apoptosis lossis inhibiting kev loj hlob ntawm cov qog hlwb. Tsis tas li ntawd, survodutide kuj qhia tau qee qhov zoo hauv kev tswj lub cev tiv thaiv kab mob, thiab tuaj yeem txhim kho lub cev tiv thaiv kab mob rau cov kab mob txawv teb chaws lossis cov qog nqaij hlav cancer. Piv nrog rau cov tshuaj me me me me, cov tshuaj peptide muaj cov tshuaj biocompatibility zoo dua thiab txo cov tshuaj toxicity, tuaj yeem ua kom raug mob ntau dua, thiab txo qis kev puas tsuaj rau cov ntaub so ntswg, uas ua rau lawv muaj kev cia siab zoo hauv kev kho mob qog noj ntshav thiab kev tiv thaiv kab mob.
Xa kev nug
Hauj lwm lawm
Kev tsis

 

Khoom Taw Qhia

Lub npe:Survodutide

Cov txiaj ntsig ntawm cov khoom:Regulates lub cev tiv thaiv kab mob

CAS:2805997-46-8

Lub peev xwm:10mg / vial

Daim ntawv foos:Dawb los yog dawb hmoov hmoov(Peptides)

Lub neej txee:{{0 {0}} xyoo (ntim khoom ntim hnub yuav tsum yeej)

Taw qhia rau Peptide Retodetide

 

**Survodutide ** yog cov tshuaj peptide feem ntau siv los kho cov kab mob metabolic, tshwj xeeb tshaj yog cov muaj feem cuam tshuam nrog insulin tsis kam thiab rog. Nws yog ib qho hluavtaws peptide, feem ntau yog tsim los ntawm ntau cov amino acids, nrog rau kev ua haujlwm zoo ib yam li cov biomolecules ntuj, tab sis nws cov qauv thiab cov khoom tau raug kho kom zoo los txhim kho nws cov txiaj ntsig thiab txhim kho nws cov tshuaj pharmacokinetic. Survodutide yog ib qho ntawm cov tshuaj peptide tshiab uas tau nyiam ntau yam hauv thaj chaw ntawm cov kab mob metabolic nyob rau xyoo tas los no, tshwj xeeb tshaj yog nws txoj kev txhim kho ntawm insulin rhiab heev thiab tswj qhov hnyav.

 

### Lub cev thiab tshuaj muaj zog:

Surrodutide yog tshuaj nrog cov qauv polypeptide, feem ntau yog cov qauv hluavtaws me me peptide lossis cov enzymes hauv lub cev kom ua haujlwm rau lub cev muaj kev tawm tsam. Vim yog nws cov protein cov khoom, nws cov tshuaj lom neeg zoo sib xws rau lwm cov tshuaj peptide, xws li insulin, glp -1, thiab lwm yam.

- ** Molecular hnyav **: Resodutide feem ntau muaj cov molecular hnyav, feem ntau nyob rau hauv ntau txhiab daltons (da), thiab yog macromolecular tshuaj.

- ** Solubility **: Feem ntau hais lus, Rollodutide yaj nyob rau hauv dej los yog cov kev daws teeb meem uas muaj me me ntawm lwm yam kev daws teeb meem yog nyob ntawm nws cov amino acid lead thiab kev hloov kho.

- ** Stability **: Raws li nws yog polypeptide, Survodutide muaj cov tshuaj lom neeg tsis tshua muaj kev ruaj ntseg thiab yooj yim cuam tshuam los ntawm yam xws li kub thiab acid-puag ib puag ncig. Yog li ntawd, nws feem ntau yuav tsum tau muab khaws cia rau hauv qhov tsim nyog, tsis txhob muaj qhov kub thiab txias.

 

### Charmacological Action thiab Txheem:

Lub ntsiab txheem tseem ceeb ntawm kev ua ntawm Defodutide yog ze ze rau kev tswj cov metabolism thiab insulin rhiab. Nws ua kom muaj kev pom zoo ntawm cov phiajcim kev sib tw, yog li txhim kho cov metabolism hauv cov metabolism, txhim kho kev txo cov ntaub so ntswg. Cov txheej txheem tshwj xeeb yuav koom nrog ntau txoj hauv kev, suav nrog:

- Txhim kho cov tshuaj insulin.

- Txhawb kev oxidation ntawm fatty acids thiab txo cov roj zuj zus.

- Txhim kho cov piam thaj metabolism thiab txo cov ntshav qab zib.

Cov teebmeem no ua rau Survodutide muaj peev xwm sib tw rau kev kho cov kab mob metabolic xws li rog thiab ntshav qab zib.

 

### Dosage:

Qhov koob tshuaj ntawm Survodutide feem ntau yog txiav txim raws li tus kab mob tshwj xeeb thiab tus neeg mob tus mob. Cov ntawv ntau npaum li cas thiab cov kev kho mob tej zaum yuav muaj qhov sib txawv ntawm cov tshuaj. Feem ntau hais lus, qhov ntau npaum ntawm Survodutide tuaj yeem muaj los ntawm ob peb milligrams mus rau kaum milligrams. Cov koob tshuaj tshwj xeeb yuav tsum tau hloov kho raws li qhov sib txawv ntawm tus neeg mob, qhov hnyav ntawm tus kab mob thiab cov hom phiaj kho mob.

- ** Ntau npaum li cas **: Hauv kev sim tshuaj, qhov ntau npaum ntawm Survodutide feem ntau yog tsim raws li lub cev qhov hnyav lossis cov yam ntxwv pathological. Piv txwv li, hauv kev sim ntsuas qhov hnyav, qhov ntau npaum li cas yuav yog 10-30 mg txhua zaus, uas yog maj mam hloov raws li tus neeg mob lub siab ntev.

 

### Ib nrab-life thiab pharmacokinetics:

Raws li peptide tshuaj, rigodutide feem ntau muaj luv luv ib nrab-lub neej. Peptide siv yeeb tshuaj yog metabolized sai nyob rau hauv lub cev thiab feem ntau yuav tsum tau muab los ntawm kev txhaj tshuaj lossis lwm txoj kev vim tias lawv yooj yim nyob rau hauv lub plab zom mov.

- ** ** Ib nrab-lub neej **: Ib nrab-lub neej ntawm Defrodutide feem ntau luv, tab sis lub sijhawm tshwj xeeb nyob ntawm tus kheej sib txawv thiab txoj kev tswj hwm.

- ** Pharmacokinetics **: Txij li Survodutide yog peptide molecule, nws nqus, faib thiab tshem tawm cov txheej txheem hauv lub cev yuav nyuaj heev. Nws feem ntau yog muab los ntawm kev txhaj tshuaj, thiab tom qab txhaj tshuaj subcutaneous, nws tau sai sai absorbed, faib thoob plaws hauv lub cev, thiab metabolized thiab tawm los ntawm cov kabmob xws li lub siab thiab ob lub raum.

 

### Lub voj voog:

Lub voj voog koob tshuaj ntawm Survodutide feem ntau yog txiav txim siab los ntawm lub hom phiaj kev kho mob thiab kev kho mob tsim. Raws li cov kev tshawb fawb uas twb muaj lawm, kev txhaj tshuaj tsis tu ncua feem ntau yog siv los tswj kom muaj txiaj ntsig zoo ntawm cov tshuaj hauv lub cev.

- ** Kev Kho Mob **: Qhov ntev ntawm chav kho mob nyob ntawm tus neeg mob hom kab mob thiab cov lus teb kho mob. Piv txwv li, rau cov neeg mob rog rog lossis insulin tsis kam, nws yuav siv sij hawm ntau lub hlis ntawm kev kho mob kom ua tiav cov txiaj ntsig zoo ntawm cov metabolism.

- ** Dosing zaus **: Feem ntau ib zaug ib lub lim tiam lossis ib zaug txhua ob lub lis piam, nyob ntawm kev tshawb nrhiav kev tsim qauv thiab cov neeg mob.

 

### Daim ntawv thov kev kho mob:

Lub chaw kuaj mob tseem ceeb ntawm Surrodutide yog kev kho mob ntawm cov kab mob metabolic xws li rog, cov tshuaj tiv thaiv insulin. Los ntawm kev txhim kho cov neeg siv metabolic, nws tuaj yeem pab cov neeg mob ua tiav phaus poob, kev tswj ntshav qab zib thiab lwm yam kev txhim kho kev noj qab haus huv.

 

### Kev phiv thiab txaus ntshai:

Zoo li ntau lwm yam tshuaj peptide, Survodutide kuj tseem muaj qee yam kev phiv, tshwj xeeb tshaj yog thaum siv tsis raug lossis ntau dhau. Cov kev mob tshwm sim muaj xws li:

- ** Pasphotioninal tsis ncaj ncees **: xws li xeev siab, ntuav, raws plab, thiab lwm yam.

- **Qhov chaw txhaj tshuaj**: Cov mob hauv zos, liab, o lossis nodules tuaj yeem tshwm sim.

- ** Hypoglycemia **: Tshwj xeeb tshaj yog siv sib xyaw ua ke nrog lwm tus hypoglycemic tshuaj xws li insulin, nws yuav nce txoj kev pheej hmoo ntawm hypoglycemia.

Nyob rau hauv luv luv, rigodutide yog ib tug muaj peev xwm siv tshuaj peptide uas yog siv los txhim kho cov tsos mob metabolic, tshwj xeeb tshaj yog nyob rau hauv kev tswj hnyav thiab insulin rhiab. Txawm li cas los xij, zoo li txhua cov tshuaj, nws yog qhov tsim nyog los ua raws li tus kws kho mob cov lus qhia thaum siv nws, tsis txhob muaj ntau dua saib xyuas thiab ze saib cov kev mob tshwm sim.

24

 

Peptide retodutide yog haum rau tib neeg

 

Survodutide (Suav lub npe: Suvodutide) yog ib hom tshuaj peptide tshiab, feem ntau yog siv los kho cov kab mob ntsig txog insulin tsis kam thiab ntshav qab zib, tshwj xeeb tshaj yog cov neeg mob ntshav qab zib hom 2. Cov hauv qab no yog cov lus qhia ntxaws ntxaws rau Survodutide, suav nrog nws cov pej xeem siv, txoj hauv kev ua haujlwm, thiab cov ntaub ntawv ntawm kev siv thiab ntau npaum li cas:

 

### 1. Cov pej xeem siv

Surrodutive yog feem ntau haum rau cov neeg hauv qab no:

- ** Cov neeg mob uas muaj cov ntshav qab zib hom 2 ** Rollodutide yog tshuaj rau cov neeg mob Hom 2 ).

- ** QIS lossis cov neeg muaj rog lossis cov neeg rog rog **: Vim tias Surodutide pab kom yuag, nws yog qhov tshwj xeeb rau cov neeg mob ntshav qab zib nrog kev rog.

- **Cov neeg muaj kev pheej hmoo siab ntawm kab mob plawv**: Qee qhov kev tshawb fawb tau pom tias Survodutide muaj txiaj ntsig zoo rau cov neeg mob ntshav qab zib hom 2 uas muaj kev pheej hmoo ntawm cov kab mob plawv.

 

### 2. Txoj Cai Ua Haujlwm

Survodutide yog **GLP-1 receptor agonist** (glucagon-zoo li peptide-1 receptor agonist), uas simulates lub luag haujlwm ntawm GLP-1 (glucagon-zoo li peptide-1) ) hauv tib neeg lub cev thiab ua lub luag haujlwm hauv qab no:

- ** Txhawb nqa insulin secretion **: Thaum cov ntshav qab zib nce siab tom qab noj mov, Survodutide txhawb kev tso tawm ntawm cov tshuaj insulin los ntawm pancreatic cells, txo cov ntshav qab zib tom qab noj mov.

- ** inhibit glucagon secretion **: Survodutide tuaj yeem cuam tshuam qhov tso tawm ntawm glucagon los ntawm pancreatic cells, yog li txo qis cov piam thaj hauv siab thiab tswj cov ntshav qab zib ntxiv.

- ** Ua kom lub plab zom mov qeeb **: Los ntawm kev ua kom lub plab zom mov qeeb, Survodutide tuaj yeem ua rau kom satiety, pab tswj kev qab los noj mov, thiab pab kom poob phaus.

- ** Txhim kho cov insulin rhiab heev **: rigodutide tuaj yeem nce insulin rhiab rhiab, tso cai rau lub cev kom siv cov tshuaj insulin ntau dua thiab tswj cov ntshav qab zib.

Hauv cov ntsiab lus, cov rollodutide tsis tsuas yog pab tswj ntshav qab zib, tab sis kuj muaj kev cuam tshuam ntev txog cov neeg mob ntshav qab zib los ntawm kev txhim kho cov insulin muaj nuj nqi thiab txo qhov hnyav.

 

### 3. Kev siv thiab ntau npaum li cas

Surrodutive yog feem ntau muab los ntawm ** Kev txhaj tshuaj subcutaneous **. Qhov kev siv tshwj xeeb thiab kev siv tshuaj yog nyob ntawm tus neeg mob, theem ntshav qab zib thiab tus kws kho mob cov lus qhia. Kev siv ntau yam thiab ntau npaum li cas suav nrog:

- ** Thawj zaug koob **: Feem ntau, koob tshuaj pib tsis muaj kev mob siab dhau hypoglycemia thiab kev tsis xis nyob. Feem ntau pib los ntawm ** {{0. 5 mg **, txhaj ib zaug ib lub lim tiam.

- ** KHO NQI QHIA **: Tom qab pib hloov kho, kev kho cov tshuaj kho tau nce ntxiv rau ** 1.}} Pa nyem txhua lub lim tiam yog tswj hwm.

- ** Kev txhaj tshuaj txuj **: Rigodutide yog feem ntau yog tus cwj mem ua ntej. Cov neeg mob tuaj yeem txhaj lawv tus kheej raws li kws kho mob cov lus qhia. Lub vev xaib txhaj tshuaj feem ntau yog tus ncej puab lossis plab.

- ** Kho koob tshuaj **: Cov koob tshuaj tuaj yeem nce ntxiv raws li tus neeg mob cov ntshav qabzib tswj thiab ua siab ntev. Yog tias tsis xis nyob lossis cov tsos mob hypoglycemia tshwm sim, tus kws kho mob yuav kho cov koob tshuaj raws li xav tau.

 

### 4. Tej yam tshwm sim

Survodutide, zoo li lwm yam GLP-1 receptor agonists, tej zaum yuav ua rau muaj qee yam kev phiv, tshwj xeeb tshaj yog kev mob plab hnyuv. Cov kev mob tshwm sim muaj xws li:

- ** xeev siab, ntuav, raws plab**: Cov no yog cov kev mob tshwm sim tshwm sim thaum siv GLP-1 receptor agonists, tab sis lawv feem ntau yooj yim dhau sijhawm.

- ** Hypoglycemia **: Tej zaum yuav muaj kev pheej hmoo ntawm hypoglycemia, tshwj xeeb tshaj yog thaum siv sib xyaw ua ke nrog lwm tus hypoglycemic (xws li insulin).

- ** XIM APPSETITE **: Vim tias REEGrodutide yuav ua rau muaj kev zam txim ntau, qee tus neeg mob yuav muaj kev noj qab haus huv lossis poob ceeb thawj.

- ** Kev kho cov kev tshuaj xyuas kev tawm tsam **: Qee tus neeg mob yuav muaj kev rov qab, o lossis tsis xis nyob ntawm qhov chaw txhaj tshuaj.

Zuag qhia tag nrho, kev phiv los ntawm Deamodutide feem ntau me thiab cov neeg mob feem ntau tuaj yeem tiv taus lawv. Nws yog ib qho tseem ceeb kom koj tus kws kho mob thaum siv kom paub tseeb tias cov tshuaj no yog qhov tsim nyog thiab kho cov nyhuv tsim nyog.

 

### Cov ntsiab lus

Surrodutide yog ib qho tshuaj tshiab tshiab rau kev kho mob ntshav qab zib hom 2. Nws pab txhim kho cov insulin zais cia, txo cov ntshav qab zib, thiab muaj qhov hnyav ntawm kev txhim kho insulin rhiab heev los ntawm ntuj glp {1}}. Nws yog feem ntau txhaj ib zaug ib lub lim tiam thiab muaj qhov zoo siab rau siab. Nws yog qhov tseem ceeb tshwj xeeb rau cov neeg mob uas muaj ntshav qab zib hom 2, kev rog thiab nws yog qhov kev siv hluav taws xob zoo siab thaum siv thiab kho cov tshuaj raws li kws kho mob cov lus qhia.

26

 

Cov txiaj ntsig ntawm Peptide Retodetide

 

**Survodutide** (lub npe scientific: TTP273) yog ib hom tshuaj peptide tshiab thiab ua haujlwm ntev GLP-1 (glucagon-zoo li peptide-1) receptor agonist. Cov tshuaj no yog siv dav hauv kev kho mob ntshav qab zib, tshwj xeeb tshaj yog hom 2 mob ntshav qab zib. Raws li GLP-1 receptor agonist, Survodutide tau txais kev saib xyuas zoo hauv kev kho mob ntshav qab zib vim nws tuaj yeem txhim kho cov ntshav qab zib thiab muaj ntau yam txiaj ntsig tshaj li cov tshuaj hypoglycemic. Cov hauv qab no yog cov lus qhia ntxaws ntxaws rau Survodutide, npog nws cov txheej txheem, cov txiaj ntsig kho mob, thiab cov teebmeem kev noj qab haus huv.

 

### 1. ** Lub cev pharmacological

Survodutide activates GLP-1 receptor los ntawm kev ua raws li qhov kev txiav txim ntawm ntuj GLP-1 hormone hauv tib neeg lub cev. GLP-1 yog ib yam tshuaj uas tso tawm los ntawm txoj hnyuv, feem ntau yog zais tom qab noj mov, thiab tuaj yeem tswj cov ntshav qab zib los ntawm ntau lub tswv yim. Survodutide tuaj yeem txhim kho qhov tso tawm ntawm insulin thiab inhibit qhov tso tawm ntawm glucagon, uas pab txo qis cov piam thaj tso tawm ntawm daim siab. Tsis tas li ntawd, Survodutide tseem tuaj yeem ncua kev ua pa ntawm plab, pab txo qis cov piam thaj hauv ntshav tom qab.

 

### 2. ** Retodutide tswj cov ntshav qab zib **

Hauv kev tshawb fawb soj ntsuam, Survodutide tau pom cov teebmeem hypoglycemic tseem ceeb. Nws pab txo qis ntshav qab zib tom qab los ntawm kev nce cov tshuaj insulin (thaum cov ntshav qab zib nce siab), inhibiting glucagon tso tawm (tiv thaiv cov piam thaj ntau dhau los ntawm lub siab), thiab ua rau lub plab zom mov.

Piv nrog tsoosyclycemic siv yeeb tshuaj, rigodutide muaj cov txiaj ntsig hauv qab no:

- **Nyob ib nrab-lub neej**: Piv nrog rau ntau yam luv luv GLP-1 receptor agonists, Survodutide muaj ib nrab-lub neej ntev, yog li nws tuaj yeem txhaj tshuaj ib zaug ib lim tiam, txhim kho kev ua raws li tus neeg mob.

- ** Dual mechanism **: Los ntawm ob lub tswv yim ntawm kev txhim kho insulin tso tawm thiab inhibiting glucagon secretion, Survodutide tuaj yeem tswj cov ntshav qab zib kom ntau dua thiab ua tau zoo.

 

### 3. ** Kev tswj hwm qhov hnyav **

Lwm qhov txiaj ntsig tseem ceeb ntawm Surceodutide yog nws cov nyhuv ntawm kev tswj hwm qhov hnyav. Vim tias nws tau ua kom sov plab zom mov thiab ua kom muaj kev vam meej Satiety, ntau tus neeg muaj ntshav qab zib tshaj tawm poob qis tom qab siv Rigodutide. Cov kev tshawb fawb pom tau tias Deurodutide tuaj yeem txhawb kom yuag poob thaum kho cov txiaj ntsig zoo lossis rog rau ntau tus neeg muaj ntshav qab zib. Tshwj xeeb, muaj ib qho sib txuas ntawm kev rog rog thiab hom ntshav qab zib hom 2, thiab kev tswj qhov hnyav thiab kev tswj hwm qhov hnyav ntawm txoj kev kho mob.

- ** Txo cov qab los noj mov **: los ntawm kev ua yeeb yam ntawm nruab nrab lub paj hlwb, rollodutide tuaj yeem txo qis qab los noj mov.

- Yak satiety **: Qeeb rau lub plab khoob pab cov neeg mob hnov ​​qab ntev dua tom qab noj mov thiab txo cov caij nyoog ntawm overeating.

 

### 4. **Cov txiaj ntsig plawv**

Cov neeg muaj ntshav qab zib feem ntau yog qhov kev pheej hmoo siab ntawm cov kab mob plawv, thiab muaj sia nyob rau hauv {}} Tam sim no cov teebmeem, kuj tau pom qee qhov kev tiv thaiv kab mob plawv. Ntau cov kev tshawb fawb tau pom tias GLP -1 Cov txheej txheem no tuaj yeem txo qis kev pheej hmoo ntawm cov neeg mob ntshav qab zib.

Tej yam tshwm sim muaj xws li:

- ** Txo txoj kev pheej hmoo ntawm lub plawv nres thiab mob stroke **: Rigoodutide tuaj yeem txo cov kev tswj hwm ntshav qab zib, txo qhov hnyav thiab txo cov ntshav siab.

- ** Kev tshawb fawb txog ntshav lipid **: Muaj qee yam kev xaiv los txo cov roj ntsha thiab cov kev pheej hmoo ntawm cov kev pheej hmoo ntawm cov kab mob plawv.

 

### 5. ** Txo cov ntshav siab**

GLP-1 receptor agonists, suav nrog Survodutide, tau pom tias muaj qee yam cuam tshuam rau ntshav siab. Cov kev sim tshuaj tau pom tias Survodutide tuaj yeem txo qis cov neeg mob systolic thiab diastolic ntshav siab. Txawm hais tias cov nyhuv no tsis tseem ceeb, nws yog ib qho txiaj ntsig ntxiv rau cov neeg mob ntshav qab zib uas muaj teeb meem ntshav siab.

 

### 6. **Lwm cov txiaj ntsig metabolic**

Selodutide tseem qhia tau zoo rau lwm cov teeb meem meabolic, tshwj xeeb tshaj yog nyob rau hauv kev kho mob ntshav qab zib tej yam:

- ** Txhim kho cov metabolism rog **: Rigodutide yuav muaj cov txiaj ntsig zoo rau cov rog rog rog, suav nrog kev nce qib visceral.

- ** Txo cov ntshav qab zib hlav Surrodutide tuaj yeem cuam tshuam cov khoom siv no rau qee yam thiab txhim kho tus neeg mob metabolic noj qab haus huv.

- ** Kev tiv thaiv daim siab **: Los ntawm kev txo cov ntshav qab zib hloov pauv, Survodutide muaj peev xwm txo tau daim siab puas xws li daim siab rog hauv cov neeg mob ntshav qab zib.

 

### 7. 4 Cov peev xwm tshwm sim los ntawm kev siv Deamodutide **

Txawm hais tias muaj txiaj ntsig tseem ceeb ntawm Survodutide, kev siv cov tshuaj twg tuaj yeem nrog qee yam kev mob tshwm sim. Raws li kev sim tshuaj tam sim no thiab cov neeg mob tawm tswv yim, qee qhov kev mob tshwm sim ntawm Survodutide suav nrog:

- ** Mas lub plab zom mov ": xws li xeev siab, ntuav, raws plab, uas feem ntau tshwm sim nyob rau hauv lub sijhawm ntxov ntawm kev kho mob thiab muaj kev cuam tshuam li lub cev hloov mus rau cov tshuaj.

- **Hypoglycemia**: Thaum siv nrog lwm cov tshuaj hypoglycemic, Survodutide tuaj yeem ua rau muaj kev pheej hmoo ntawm hypoglycemia, tshwj xeeb tshaj yog thaum siv nrog cov tshuaj insulin lossis sulfonylurea.

- **Qhov chaw txhaj tshuaj**: Vim tias Survodutide yuav tsum tau txhaj, qee cov neeg mob yuav hnov ​​​​mob liab, o, mob thiab lwm yam kev cuam tshuam ntawm qhov chaw txhaj tshuaj.

 

### 8. **Cov Lus Qhia thiab Cov Neeg Mob**

Survodutide feem ntau yog tsim rau cov neeg mob uas muaj ntshav qab zib hom 2, tshwj xeeb tshaj yog cov neeg uas rog dhau thiab tswj tsis tau cov ntshav qab zib nrog cov tshuaj hauv qhov ncauj. Nws kuj tseem tsim nyog rau cov neeg mob ntshav qab zib uas muaj kev pheej hmoo siab plawv. Vim nws cov txiaj ntsig zoo tswj qhov hnyav, Survodutide kuj tseem suav tias yog cov tshuaj pabcuam zoo tshaj plaws rau kev kho mob rog.

 

### 9. ** Kev tshuaj xyuas kev pom zoo **

Survodutide tseem nyob rau theem kev tshawb fawb soj ntsuam, tab sis nws lub peev xwm ua GLP-1 receptor agonist tau pom dav dav. Nyob rau hauv lub neej yav tom ntej, raws li cov ntaub ntawv kho mob ntau ntxiv, Survodutide yuav tsum tau los ua ib qho kev kho mob tseem ceeb hauv kev kho mob ntshav qab zib, rog rog thiab kab mob plawv metabolic. Raws li cov kev xaiv kho mob tau ua kom zoo tsis tu ncua, Survodutide tuaj yeem dhau los ua cov cuab yeej tseem ceeb rau kev tswj cov ntshav qab zib kom ntev thiab rog.

 

### xaus

Survodutide yog cov tshuaj peptide uas muaj ntau yam txiaj ntsig, tshwj xeeb tshaj yog qhia txog kev muaj peev xwm tseem ceeb hauv kev tswj ntshav qab zib, tswj qhov hnyav thiab tiv thaiv kab mob plawv. Nws tuaj yeem tsis tsuas yog txhim kho kev tswj ntshav qab zib hauv cov neeg mob ntshav qab zib, tab sis kuj tseem muaj txiaj ntsig zoo hauv kev tswj qhov hnyav, kev noj qab haus huv ntawm lub plawv thiab lwm yam. Txawm hais tias muaj qee yam kev phiv, nws cov teebmeem mus sij hawm ntev thiab kev kho mob zoo ua rau nws yog ib qho kev xaiv tseem ceeb hauv kev kho mob ntshav qab zib thiab rog.

31

 

Hu rau Cov Lus Qhia (WhatsApp Telegram) Thiab Txoj Kev Them Nyiaj

 

WhatsApp / Telegram: +852 6749 2648

Gmail:lucasraws207@gmail.com

Skype: Nyob: .cid.8F21DC7FC6621BA7

1729737702523 1729737641865 product-570-257

 

Cov FAQ

Q: Pharmacological mechanism ntawm Survodutide

A: Streetodutide activates glp -1 Cov receptors los ntawm kev ua pa ntawm lub cev ntawm lub ntuj} {1} ormone. GLP -1 Yog cov tshuaj hormones zais los ntawm cov hnyuv, thiab tuaj yeem tswj cov ntshav qab zib los ntawm ntau lub cev. Selodutide zoo txhim kho cov khoom zais insulin thiab inhibits glucagag zais cia, uas pab txo cov piam thaj tso tawm ntawm daim siab. Tsis tas li ntawd, Rollodutide tuaj yeem ncua kev ua plab zom thiab pab txo cov ntshav qab zib tom qab noj mov.

Q: Rigodutide rau cov ntshav plab zom mov

A: Hauv kev tshawb fawb hauv kev soj ntsuam, muaj sia nyob ua rau muaj kev cuam tshuam zoo heev. Nws pab txo qis cov ntshav qab zib los ntawm kev tso tawm cov insulin (tiv thaiv cov kab piam thaj hauv kev tso tawm), inhiberming glucium tso tawm), inhiberming glucon tso tawm los ntawm daim siab tsoos), thiab kev ncua plab.
Piv nrog cov tshuaj ib txwm muaj tshuaj antidiabetic tshuaj, rigodutide muaj cov txiaj ntsig hauv qab no:
- **Nyob ib nrab-lub neej**: Muab piv rau ntau yam luv luv GLP-1 receptor agonists, Survodutide muaj ib nrab neej ntev, yog li nws tuaj yeem txhaj tshuaj ib zaug ib lub lim tiam, txhim kho kev ua raws li tus neeg mob.
- ** Dua ob qho tib yam ntxwv ": los ntawm kev txhim kho insulin zais cia, rigodutide tuaj yeem tswj cov ntshav qab zib ntau dua thiab muaj txiaj ntsig zoo.

 

Cim npe nrov: Peptides Retodutide 10Mg CAS: {{{{}}}}, Tuam Tshoj Peptides DeAfrodetide 10Mg Cas:} Cov neeg tsim khoom, cov chaw tsim khoom, Hoobkas

Xa kev nug
Auctus Steroid Pharma Co., Ltd
Muab cov kev pab cuam tom qab muag tiav, suav nrog cov khoom xa rov qab thiab cov cai pauv hloov, kev ruaj ntseg zoo, thiab lwm yam.
tiv tauj peb